cbdMD (YCBD) Cost of Revenue (2016 - 2025)

cbdMD (YCBD) has 10 years of Cost of Revenue data on file, last reported at $2.0 million in Q4 2025.

• For the quarter ending Q4 2025, Cost of Revenue rose 17.67% year-over-year to $2.0 million; the trailing twelve-month figure through Dec 2025 stood at $7.5 million (up 1.94% YoY), and the FY2025 full-year result was $7.2 million, down 3.53% from the prior year.
• Cost of Revenue climbed to $2.0 million in Q4 2025, from $1.9 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $4.3 million in Q4 2021 to a low of $1.7 million in Q4 2024.
• A 5-year average of $2.5 million and a median of $2.2 million in 2023 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue soared 33.35% in 2021 and tumbled 41.84% in 2022, its largest moves.
• Tracing YCBD's Cost of Revenue over 5 years: stood at $4.3 million in 2021, then plunged by 41.84% to $2.5 million in 2022, then dropped by 27.79% to $1.8 million in 2023, then declined by 5.78% to $1.7 million in 2024, then gained by 17.67% to $2.0 million in 2025.
• Business Quant data shows YCBD's Cost of Revenue at $2.0 million in Q4 2025, $1.9 million in Q3 2025, and $1.8 million in Q2 2025.